Start Date
June 30, 2003
Study Completion Date
August 31, 2004
tezacitabine
oxaliplatin
Georgetown University Medical Center, Lombardi Cancer Center, Washington D.C.
Northwestern University Feinberg School of Medicine, Chicago
Kansas City Oncology and Hematology Group, Kansas City
ACRC/Arizona Clinical Research Center, Tucson
USC/Norris Comprehensive Cancer Center, Los Angeles
Cancer Institute Medical Group, Santa Monica
Comprehensive Cancer Centers of the Desert, Palm Springs
H. Lee Moffitt Cancer Center & Research Institute, Tampa
Lead Sponsor
Chiron Corporation
INDUSTRY